Christian Lynch joined the FDA in June 2003 as a Biologist in the Office of Vaccines Research and Review. In October 2008, Mr. Lynch moved to ORA as an investigator with Team Biologics and was responsible for conducting highly technical and complex systems based inspections of CBER licensed biologic drug and device manufacturers (domestic and international). In February 2014, Mr. Lynch joined the Office of Compliance and Biologics Quality (OCBQ), Division of Manufacturing and Product Quality (DMPQ) as a Consumer Safety Officer responsible for CMC/facility review of Biologics License Applications and supplements, NDAs, and PMAs for CBER regulated products and medical devices. In addition to regulatory review, Mr. Lynch is responsible for conducting Pre-License and Pre-Approval Inspections of biologics manufacturing facilities. Currently, Mr. Lynch is serving as an Acting Team Lead in DMPQ.